Lanean...
Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use
BACKGROUND: Sitagliptin is a new oral glucose lowering medication which acts via the incretin hormone system. The most common side effects are headache and pharyngitis, and few serious adverse events were observed during clinical trials. Dose adjustment is recommended in renal insufficiency, but lon...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2602841/ https://ncbi.nlm.nih.gov/pubmed/19046202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-5491.2008.02536.x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|